Carsten A. Vock

Development of Ruthenium Antitumor Drugs that Overcome Multidrug Resistance Mechanisms

Carsten A. Vock, Wee Han Ang, C. Scolaro et al. · Journal of Medicinal Chemistry · 2007 · 186 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Synthesis, Characterization, and in Vitro Evaluation of Novel Ruthenium(II) η⁶-Arene Imidazole Complexes

Carsten A. Vock, C. Scolaro, A.D. Phillips et al. · Journal of Medicinal Chemistry · 2006 · 143 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +16

Influence of the Diketonato Ligand on the Cytotoxicities of [Ru(η⁶‐<i>p</i>‐cymene)(R₂acac)(PTA)]⁺ Complexes (PTA = 1,3,5‐triaza‐7‐phosphaadamantane)

Carsten A. Vock, Anna K. Renfrew, Rosario Scopelliti et al. · European Journal of Inorganic Chemistry · 2008 · 91 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +12

First Selective CYP11B1 Inhibitors for the Treatment of Cortisol-Dependent Diseases

Ulrike E. Hille, Christina Zimmer, Carsten A. Vock et al. · ACS Medicinal Chemistry Letters · 2010 · 79 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Novel CYP17 inhibitors: Synthesis, biological evaluation, structure–activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls

Ulrike E. Hille, Qingzhong Hu, Carsten A. Vock et al. · European Journal of Medicinal Chemistry · 2009 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17